REFERENCES
- Klaassen I, Neuhaus TJ, Mueller-Wiefel DE, Kemper MJ. Antenatal oligohydramios of renal origin: Long-term outcome. Nephrol Dial Transplant 22:432–439, 2007.
- OMIM: RENAL ADYSPLASIA. http://www.ncbi.nlm.nih.gov/entrez/dispomin.cgi?id=191830.
- Curry CJ, Jensen K, Holland J, Miller L, Hall BD. The Potter Sequence: Clinical analysis of 80 cases. American Journal of Medical Genetics 19:679–702, 1984.
- Leuthner S, Jones EL. Fetal Concerns Program: A model for perinatal palliative care. MCN Am J Matern Child Nurs 32(5):272–278, 2007.
- Chervenak, FA, McCullough, LB. Ethical isssues in recommending and offering fetal therapy. Western Journal of Medicine,159;396–399, 1993.
- Breeze AC, Lees CC, Kumar A, Missfelder-Lobos HH, Murdoch EM. Palliative care for pregnancy diagnosed lethal fetal abnormality. Archives of Disease in Childhood. Fetal and Neonatal Edition 92:F56–F58, 2007.
- Drotar D, Baskiewicz A, Irvin N, Kennell J, Klaus M. The adaptation of parents to the birth of an infant with a congenital malformation: A hypothetical model. Pediatrics 56(5):710–717, 1975.
- Saji H, Yamanaka M, Hagiwara A, Ijiri R. Losartan and fetal toxic effects. Lancet 3; 357–363, 2001.